Cytotoxicity of silver dressings on diabetic fibroblasts

International Wound Journal

Volumn 10, Issue 3, 2013, Pages 306-312

  Zou, Shi Bo ^a   Yoon, Won Young ^b   Han, Seung Kyu ^b   Jeong, Seong Ho ^b   Cui, Zheng Jun ^a   Kim, Woo Kyung ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b Korea University College of Medicine   (South Korea)

Author keywords

Cytotoxicity; Diabetic fibroblasts; Silver dressing

Indexed keywords

ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOPLASM; DIABETES MELLITUS; DRUG CYTOTOXICITY; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; SILVER DRESSING;

BANDAGES; BURNS, CHEMICAL; CELL PROLIFERATION; CELLS, CULTURED; DIABETIC FOOT; FEMALE; FIBROBLASTS; HUMANS; MALE; MIDDLE AGED; SILVER;

EID: 84878135882     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2012.00977.x     Document Type: Article

References (43)

1. Russell AD, Hugo WB. Antimicrobial activity and action of silver. Prog Med Chem 1994;31:351-70.
2. Dunn K, Edwards-Jones V. The role of Acticoat™ with nanocrystalline silver in the management of burns. Burns 2004;30:S1-S9.
3. Tomaselli N. The role of topical silver preparations in wound healing. J Wound Ostomy Continence Nurs 2006;33:367-80.
4. Hollinger MA. Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol 1996;26:225-60.
5. Wright B, Lam K, Buret A, Olson ME, Burrell RE. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen 2002;10:141-51.
6. Fong J, Wood F. Nanocrystalline silver dressings in wound management: a review. Int J Nanomedicine 2006;1:441-9.
7. Mooney EK, Lippitt C. Friedman Jeff. Silver dressings. Plast Reconstr Surg 2006;117:666-9.
8. Lansdown AB, Sampson B, Laupattarakasem P, Vuttivirojana A. A Silver aids healing in the sterile skin wound: experimental studies in the laboratory rat. Br J Dermatol 1997;137:728-35.
9. Lansdown AB. Metallothioneins: potential therapeutic aids for wound healing in the skin. Wound Repair Regen 2002;10:130-2.
10. Bador K. Organ deposition of silver following silver nitrate therapy for burns. Plast Reconstr Surg 1966;37:550-1.
11. Baños AM, Nogueras Flores I, Palomar Llatas F. Clinical evaluation of a silver dressing in the treatment of infected and colonized ulcers. Rev Enferm 2008;31:42-8.
12. Tredget E, Shankowsky HA, Groeneveld A, Burrell R. A matched pair randomized study evaluating the efficacy and safety of Acticoat silver coated dressing for the treatment of burn wounds. J Burn Care Rehabil 1998;19:531-7.
13. Coombs CJ, Wan AT, Masterton JP, Conyers RA, Pedersen J, Chia YT. Do burn patients have a silver lining? Burns 1992;18:179-84.
14. Wilkinson LJ, White RJ, Chipman JK. Silver and nanoparticles of silver in wound dressings: a review of efficacy and safety. J Wound Care. 2011;20:543-9.
15. Yin H, Langford R, Burrell R. Comparative evaluation of the antimicrobial activity of Acticoat antimicrobial barrier dressing. J Burn Care Rehabil 1999;20:195-200.
16. Demling RH, DeSanti L. The rate of re-epithelializa tion across meshed skin grafts is increased with exposure to silver. Burns 2002;28:264-6.
17. Lohsiriwat V, Chuangsuwanich A. Comparison of the ionic silver-containing Hydrofiber* and paraffin gauze dressing on split-thickness skin graft donor sites. Ann Plast Surg 2009;62:421-2.
18. Burd A, Kwok CH, Hung SC, Chan HS, Gu H, Lam WK, Huang L. A comparative study of the cytotoxicity of silver-based dressings in monolayer cells, tissue explant, and animal models. Wound Repair Regen 2007;15:94-104.
19. Paddle-Ledinek JE, Nasa Z, Cleland HJ. Effect of different wound dressings on cell viability and proliferation. Plast Reconstr Surg 2006;117:110S-8S.
20. Poon VK, Burd A. In vitro cytotoxity of silver: implication for clinical wound care. Burns 2004;30:140-7.
21. Monafo WW, Moyer CA. The treatment of extensive thermal burns with 0.5 percent silver nitrate solution. Ann N Y Acad Sci 1968;150:937-45.
22. Fox CL Jr. Silver sulfadiazine-a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg 1968;96:184-8.
23. Bellinger CG, Conway N. Effects of silver nitrate and sulfamylon on epithelial regeneration. Plast Reconstr Surg 1970;45:582-5.
24. Scapicchio AP, Constable JD, Opitz B. Comparative effects of silver nitrate and sulfamylon on epidermal regeneration. Plast Reconstr Surg 1968;41:319-22.
25. Niedner R, Schöpf E. Inhibition of wound healing by antiseptics. Br J Dermatol 1986;115:41-4.
26. Lansdown ABG, Williams A. How safe is silver in wound care? J Wound Care 2004;13:131-6.
27. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2001;26:131-8.
28. Bolton L. Are silver products safe and effective for chronic wound management? J Wound Ostomy Continence Nurs 2006;33:469-77.
29. Modak SM, Fox CL Jr. Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem Pharmacol 1973;22:2391-404.
30. Rosenkranz HS, Rosenkranz S. Silver sulfadiazine: interaction with isolated deoxyribonucleic acid. Antimicrob Agents Chemother 1972;2:373-83.
31. Hatchett DW, Josowicz M. Composites of intrinsically conducting polymers as sensing nanomaterials. Chem Rev 2008;108:746-9.
32. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 2007;73:1712-20.
33. Shrivastava S, Bera T, Singh SK, Singh G, Ramachandrarao P, Dash D. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano 2009;3:1357-64.
34. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for gram-negative bacteria. J Colloid Interface Sci 2004;275:177-82.
35. +. Biochemistry 2005;44:13214-23.
36. Solioz M, Odermatt A. Copper and silver transport by CopB-ATPase in membrane vesicles of Enterococcus hirae. J Biol Chem 1995;270:9217-21.
37. Rogers KS. Variable sulfhydryl activity toward silver nitrate by reduced glutathione and alcohol, glutamate and lactate dehydrogenases. Biochim Biophys Acta 1972;263:309-14.
38. Dunn K, Edwards-Jones V. The role of Acticoat with nanocrystalline silver in the management of burns. Burns 2004;30:S1-S9.
39. Lansdown AB. Silver. I: its antibacterial properties and mechanism of action. J Wound Care 2002;11:125-30.
40. Jones SA, Bowler PG, Walker M, Parsons D. Controlling wound bioburden with a novel silver-containing Hydrofiber dressing. Wound Repair Regen 2004;12:288-94.
41. McNeil SE, Hobson SA, Nipper V, Rodland KD. Functional calcium-sensing receptors in rat fibroblasts are required for activation of SRC kinase and mitogen-activated protein kinase in response to extracellular calcium. J Biol Chem 1998;273:1114-20.
42. 2+ stimulates the activation of mitogen-activated protein kinase and cell growth in human fibroblasts. Biochem J 1995;310:881-5.
43. Doyle JW, Roth TP, Smith RM, Li YQ, Dunn RM. Effects of calcium alginate on cellular wound healing process modeled in vitro. J Biomed Mater Res 1996;32:561-8.